Showing results (21-30 of 74) with videos related to
Sort By:
Pageof 8
Antiviral Therapy|December 19, 2002
Analysis of the virological response with respect to baseline viral phenotype and genotype in protease inhibitor-experienced HIV-1-infected patients receiving lopinavir/ritonavir therapyDale J Kempf, Jeffrey D Isaacson, Martin S King, et al.Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Novel lopinavir analogues incorporating non-Aromatic P-1 side chains--synthesis and structure--activity relationshipsHing L Sham, Chen Zhao, Leping Li, et al.Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Synthesis of potent pyrrolidine influenza neuraminidase inhibitorsA Chris Krueger, Yibo Xu, Warren M Kati, et al.Bioorganic & Medicinal Chemistry Letters|April 20, 2005
Oximinoarylsulfonamides as potent HIV protease inhibitorsClinton M Yeung, Larry L Klein, Charles A Flentge, et al.Bioorganic & Medicinal Chemistry Letters|April 1, 2008
Synthesis, antiviral activity, and conformational studies of a P3 aza-peptide analog of a potent macrocyclic tripeptide HCV protease inhibitorJohn T Randolph, Xiaolin Zhang, Peggy P Huang, et al.Bioorganic & Medicinal Chemistry Letters|October 14, 2003
Synthesis and SAR studies of potent HIV protease inhibitors containing novel dimethylphenoxyl acetates as P2 ligandsXiaoqi Chen, Dale J Kempf, Lin Li, et al.Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid coreGary T Wang, Sheldon Wang, Robert Gentles, et al.Antimicrobial Agents and Chemotherapy|November 19, 2002
Virtual inhibitory quotient predicts response to ritonavir boosting of indinavir-based therapy in human immunodeficiency virus-infected patients with ongoing viremiaNancy Shulman, Andrew Zolopa, Diane Havlir, et al.Journal of Medicinal Chemistry|September 9, 2011
P1-substituted symmetry-based human immunodeficiency virus protease inhibitors with potent antiviral activity against drug-resistant virusesDavid A Degoey, David J Grampovnik, Hui-Ju Chen, et al.Antimicrobial Agents and Chemotherapy|January 24, 2008
Characterization of a novel human immunodeficiency virus type 1 protease inhibitor, A-790742Tatyana Dekhtyar, Teresa I Ng, Liangjun Lu, et al.Pageof 8